Earnings Preview: NRX Pharmaceuticals
Portfolio Pulse from Benzinga Insights
NRX Pharmaceuticals (NASDAQ:NRXP) is scheduled to release its quarterly earnings report on November 14, 2023. Analysts predict an EPS of $-0.12. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, NRXP's stock price has reacted to past earnings performances, with a mix of positive and negative changes post-announcement. The stock is currently trading at $0.3299, down 64.57% over the last 52 weeks.
November 13, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NRX Pharmaceuticals is expected to report an EPS of $-0.12 for the upcoming earnings. Historical data shows stock price reactions to earnings results and guidance. Shares have significantly declined over the past year.
The expected EPS is a key indicator of the company's performance, and historical data suggests that NRXP's stock price can be sensitive to earnings results and forward guidance. However, the current downward trend in the stock price indicates a bearish sentiment that may not easily reverse even with a positive earnings report.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100